Boston Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston Medical Center sits in the top decile of US sponsors by registered trial count (#130 of 15,742 sponsors by registered trial count).
Boston Medical Center: 253 sponsored US clinical trials, 28 recruiting.
Boston Medical Center sponsors 253 registered US clinical trials on ClinicalTrials.gov, 28 of them currently recruiting, and 177 completed. 18 of these trials are in Phase 3-4 (later-stage) and 47 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 5 trials.
Top-decile sponsor footprint
Boston Medical Center ranks in the top decile of sponsors by registered trial count (#130 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
177 of 212 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
253 total, page 3 of 6
Does a Mindfulness Curriculum Prevent Physician Burnout During Pediatric Internship?
NCT03148626
Integrating Primary & Secondary Interventions for Cervical Cancer Prevention in Primary Care Settings
NCT03033550
Pharmacist-led Intervention on Adherence in Patients Undergoing Treatment With an Oral Oncology Medication
NCT03104114
Evaluation of Medium Chain Triglycerides in a Mixed Racial Population of Patients: a Feasibility Study
NCT02783703
Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center
NCT02867995
Daratumumab for the Treatment of Patients With AL Amyloidosis
NCT02841033
Early and Adequate Protein Feeding Post-Traumatic Injury
NCT02837861
Impact of Rapid Flu Testing in BMC ED
NCT02979730
Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
NCT02845453
Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis
NCT02716103
CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study
NCT02996032
Housing Prescriptions as Health Care
NCT02816294
Behavioral CVD Prevention Using Informatics
NCT02752464
Integrating HCV and HIV Screening During the Era of HIV Antigen Testing
NCT02869776
Translating Research Into Practice: Patient Navigation for Breast Cancer
NCT03514433
Mindfulness Based Smoking Cessation Program
NCT02795312
Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With IPAA
NCT02828410
Efficacy of Fecal Immunochemical Test Using Digital Rectal Exam
NCT03013855
Our Whole Lives: Online Chronic Pain Management
NCT02788539
Treatment of Chronic Laryngitis With Amitriptyline
NCT02552225
Long-Acting Progestin Contraception and the Vaginal Microbiome
NCT02740998
A Medical Home-Based Intervention to Prevent Child Neglect in High-Risk Families
NCT02857673
Purposeful Parenting: Enhanced Anticipatory Guidance for the First Year of Life
NCT02428465
Assessing the CenteringPregnancy Planning to Parent Innovation
NCT02856711
The Pharmacokinetics of 12 Week Continuous Patch Use
NCT02585999
Treatment of Paradoxical Vocal Fold Motion Disorder (PVFMD) With a Form of Respiratory Retraining Technique
NCT02859974
Reducing Socioeconomic Disparities in Health at Pediatric Visits
NCT02451059
Targeting Effective Analgesia in Clinics for HIV - Intervention
NCT02564341
Agent-Enhanced Document Explanation
NCT02668705
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)
NCT02417974
Mobilizing Community Networks to Optimize Child Well-being
NCT02622399
Best Beginnings for Babies Birth Sister Program Evaluation
NCT02550730
Standard Versus PICO Dressings in Lower-Extremity Bypass Patients
NCT02492854
Women in Control: A Virtual World Study of Diabetes Self-Management
NCT02726425
Targeting Effective Analgesia in Clinics for HIV - Patient Cohort
NCT02525731
Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib
NCT02489500
Patient Navigation and Financial Incentives to Promote Smoking Cessation
NCT02351609
Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression
NCT02262377
Yoga vs. Education for Veterans With Chronic Low Back Pain
NCT02224183
Weight Management Among Breast Cancer Survivors
NCT02387671
Randomized Pilot Trial of the Impact of Bedside Delivery of Discharge Medications to Pediatric Patients With Asthma
NCT02336490
Engaging Women With the Gabby System to Deliver Multiple Health-Related Behavioral Changes: A Feasibility Study
NCT02965651
Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging
NCT02510456
Treating Comorbid Depression During Care Transitions Using Relational Agents
NCT02845102
PrEPception: Expanding Assisted Reproductive Options for Serodiscordant Couples
NCT02233192
Massage Therapy Versus Music Therapy Pilot Study
NCT02227680
Socio-legal Services for Underserved Populations Through Patient Navigation to Optimize Resources During Treatment
NCT02232074
Transforming Opioid Prescribing in Primary Care
NCT01909076
Randomized Control Trial of a Virtual Patient Advocate for Preconception Care
NCT01827215
Trial of the Treatment of Chronic Laryngitis With Amitryptiline
NCT02434523
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 24 |
| Phase 3 | 9 |
| Phase 4 | 9 |
Therapeutic Areas
What is open in the Boston Medical Center pipeline
28 recruiting of 253 indexed (11% open); 177 completed (70%).
Phase mix: 18 late (III/IV) vs 47 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston Medical Center: open-pipeline peers nationwide
Peers matched on 253 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Boston Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 253 trials (± recruiting share)
- University of South Florida · 252 trials · 17% recruiting
- University of Texas at Austin · 257 trials · 23% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
Sponsors near 11% open enrollment (± trial volume)
- The Miriam Hospital · 11% recruiting · 136 trials
- ADC Therapeutics S.A. · 11% recruiting · 18 trials
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
Related
What to do with this Boston Medical Center page
253 registered trials is a research-attention snapshot, not an endorsement of Boston Medical Center or any single study.
- 28 of Boston Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Boston Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Boston Medical Center pipeline card: 253 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.